EQT EQT

Dividend
1.08%
Previous close
$59.70
Est. 12 months change
+8.09%
Projected Price
$64.58

Profitability Metrics

Return on Equity (ROE)
9.15%
Return on Assets (ROA)
5.20%
Return on Invested Capital (ROIC)
6.86%
Weighted Average Cost of Capital (WACC)
7.54%
ROIC - WACC
-0.68%
Updated : 2026-04-03 17:43 ET

Valuation Metrics

P/E Ratio
18.04
Forward P/E
12.76
PEG Ratio
1.10
Debt Current Ratio
0.76

Growth & Cash Flow

Gross Margin
60.91%
Operating Margin
39.38%
FCF Margin
34.33%
TTM Revenue Growth
46.98%
Projected 12M EPS Growth
41.35%

Price Change

Price % from 50 SMA
-1.04%
Price % from 200 SMA
6.57%
6 Months
7.07%
1 Year
9.30%
2 Years
61.92%
Click here to see the list of ETFs containing EQT as a top holding :EQT ETFs

Analysis

Company Overview

EQT Corporation is the largest natural gas producer in the United States, focused entirely on the Appalachian Basin's Marcellus and Utica shales. Sector: Energy.

Overview

EQT (EQT) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

Profitability & Capital Efficiency

On the question of capital productivity, ROIC is 6.86%, WACC is 7.54%, and the economic spread is -0.68%. On balance, the spread between returns and funding costs is negative — a dynamic that pressures intrinsic value unless operating performance improves. Supporting metrics show ROE at 9.15% and ROA at 5.20%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company that likely needs operating improvement before returns quality can be considered durable.

Valuation

Assessed on a multiple basis, trailing P/E of 18.04, forward P/E of 12.76, PEG of 1.10. Forward P/E comes in somewhat below trailing — a gap that is supportive of the valuation case without implying a sharp near-term earnings inflection. At this PEG level, the company offers what growth investors typically look for: earnings expansion priced at a reasonable relative multiple. The company carries an aggregate current ratio of 0.76, pointing to constrained near-term balance sheet coverage. Overall, the valuation setup reads as a balance between expected growth and execution risk, with liquidity acting as an important stabilizer if macro conditions become less favorable.

Margins & Cash Generation

The margin stack reads as follows: gross margin sits at 60.91%, operating margin at 39.38%, and free cash flow margin at 34.33%. Gross margins at this level typically indicate businesses with structural pricing advantages and low direct cost sensitivity. At this level, operating margins reflect businesses with genuine scalability and above-average cost control. The company's FCF margin is a standout — reflecting businesses where accounting profits translate cleanly into real cash generation. Viewed together, these readings indicate a company that converts revenue into both earnings and cash with discipline.

Growth & Forward Outlook

Where growth and expectations intersect, the estimated 12-month price change of 8.17%, where analyst estimates suggest only incremental upside absent a positive surprise, while TTM revenue growth of 46.98% suggesting the company is collectively capturing meaningful market share or pricing power. The projected 12-month EPS growth rate of 41.4% is a standout component of the forward case — meaningful earnings expansion at this scale typically warrants attention from growth-oriented investors. Both signals are useful lenses, but they tend to diverge most sharply near inflection points in both business fundamentals and market sentiment. The durability of both the operating trend and analyst optimism will determine whether the current setup translates into measurable near-term returns. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

The overall evidence base is constructive, with more signals pointing up than down and no obvious structural impairment to the forward case.

This summary is based on publicly available quantitative data and is not intended as investment advice. Carefully consider your personal financial circumstances before making any decisions.